Abstract:One week after discharge appears to be a critical period for the development of postpartum eclampsia. Education about the possibility of delayed postpartum preeclampsia and eclampsia should occur after delivery, whether or not patients develop hypertensive disease before discharge from the hospital.
“…This includes late postpartum eclampsia that may occur up to 4 to 6 weeks postpartum and that accounts for 15% of eclampsia cases without antepartum-associated diagnosis of hypertension. 21 Overall, a stepwise approach to the management of the patient with eclampsia includes (1) maternal support of vital functions; (2) control of seizure and prevention of recurrent seizures; (3) correction of maternal hypoxemia and/or acidemia; (4) control of severe hypertension to a safe range; and (5) consideration for determining timing and route of delivery. 22 Initial pharmacotherapy intervention is aimed toward reducing perinatal morbidity through seizure prophylaxis when severe features of preeclampsia manifest.…”
Section: Organ System Effects Of Hypertensive Disorders Of Pregnancymentioning
Hypertension predisposes the woman and fetus to adverse outcomes during the pregnancy and postpartum. The risk for maternal complications and neonatal morbidity associated with the necessity of preterm birth extends beyond the postpartum and postnatal period. A comprehensive review of the multisystem effects of hypertensive disorders and underlying pathophysiology is provided to support the role of prompt identification of and management of acute complications of hypertension.
“…This includes late postpartum eclampsia that may occur up to 4 to 6 weeks postpartum and that accounts for 15% of eclampsia cases without antepartum-associated diagnosis of hypertension. 21 Overall, a stepwise approach to the management of the patient with eclampsia includes (1) maternal support of vital functions; (2) control of seizure and prevention of recurrent seizures; (3) correction of maternal hypoxemia and/or acidemia; (4) control of severe hypertension to a safe range; and (5) consideration for determining timing and route of delivery. 22 Initial pharmacotherapy intervention is aimed toward reducing perinatal morbidity through seizure prophylaxis when severe features of preeclampsia manifest.…”
Section: Organ System Effects Of Hypertensive Disorders Of Pregnancymentioning
Hypertension predisposes the woman and fetus to adverse outcomes during the pregnancy and postpartum. The risk for maternal complications and neonatal morbidity associated with the necessity of preterm birth extends beyond the postpartum and postnatal period. A comprehensive review of the multisystem effects of hypertensive disorders and underlying pathophysiology is provided to support the role of prompt identification of and management of acute complications of hypertension.
“…Sometimes, preeclampsia can first manifest in the postpartum period, either after a pregnancy complicated by gestational hypertension, preexisting hypertension, or more rarely after a normotensive pregnancy [4–13]. Postpartum preeclampsia (PPPE) has been most commonly defined in the literature as a systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg on at least two occasions, 4h apart and presenting more than 48h after delivery and before 6 weeks postpartum, without the need of a proteinuria [6–8, 11, 14, 15]. The majority of studies of PPPE include women with pregnancies complicated by hypertension or preeclampsia [6–8].…”
Section: Introductionmentioning
confidence: 99%
“…Postpartum preeclampsia (PPPE) has been most commonly defined in the literature as a systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg on at least two occasions, 4h apart and presenting more than 48h after delivery and before 6 weeks postpartum, without the need of a proteinuria [6–8, 11, 14, 15]. The majority of studies of PPPE include women with pregnancies complicated by hypertension or preeclampsia [6–8]. A study of PPPE after normotensive pregnancy found that advanced maternal age (> 40 years old), Hispanic ethnicity, Black race, obesity and a history of gestational diabetes during the index pregnancy are risk factors for PPPE [11].…”
Objectives
This study aims at identifying associations between therapeutics used during labor and the occurrence of postpartum preeclampsia (PPPE), a poorly understood entity.
Study Design and Main Outcome Measures
This is a case-control study of women who received an ICD-9 code for PPPE (cases) during the years 2009–2011, compared to women with a normotensive term pregnancy, delivery and postpartum period until discharge (controls), matched on age (±1 year) and delivery date (± 3 months). Cases were defined as women having a normotensive term pregnancy, delivery and initial postpartum period (48 hrs post-delivery) but developing hypertension between 48 hrs and 6 weeks postpartum. Single variable and multiple variable models were used to determine significant risk factors.
Results
Forty-three women with PPPE were compared to 86 controls. Use of vasopressors and oxytocin did not differ between cases and controls, but rate of fluids administered during labor (OR= 1.68 per 100cc/h; 95% CI: 1.09–2.59, p=0.02) and an elevated pre-pregnancy/first trimester BMI (OR=1.18 per kg/m2, 95% CI: 1.07–1.3, p=0.001) were identified as significant risk factors in multivariate analysis.
Conclusions
We identified two potentially modifiable risk factors for PPPE; further studies are needed to better define the role of these two variables in the development of PPPE.
“…However, there are many women diagnosed with a postpartum hypertensive disorder that had no antepartum or intrapartum issues with elevated blood pressure. 2,3 Antenatal management and delivery timing for pregnancies complicated by hypertension have been a frequent focus of clinical research, but there is no evidence-based standard for postpartum surveillance that might prevent postpartum hypertension. 4,5 …”
Section: Introductionmentioning
confidence: 99%
“…This data will add to the existing literature that has identified the complications associated with postpartum hypertension by readmission data. 3 Women presenting to an ED during the postpartum period represent a population of women whose needs are not being met by our current system. Given the potentially severe complications associated with postpartum hypertension, it is important that we learn more about the symptoms and characteristics that might better predict the complication of hypertension.…”
Objectives:
To describe the characteristics of women diagnosed with postpartum hypertension in an emergency department (ED) to better inform postpartum care.
Methods:
Women with an ED diagnosis of hypertension were compared to women with all other ED diagnoses.
Results:
Among 252 postpartum women who presented for ED care, 52 were given a diagnosis of hypertension. Women with hypertension had some recognizable risk factors and presented on average within one week of delivery. Readmission rate was high, and many women seemed aware of their hypertension.
Conclusion:
Postpartum surveillance may not prevent readmission for hypertension, future focus should be in prevention interventions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.